Intestinal protein expression profile identifies inflammatory bowel disease and predicts relapse
- PMID: 23638224
- PMCID: PMC3638103
Intestinal protein expression profile identifies inflammatory bowel disease and predicts relapse
Abstract
To date, most studies have applied individual factors as indicators of disease classification and prognosis. The aim of this study is to determine whether clustering analysis of protein expression profiles in intestinal epithelia improves classification and prognosis in patients with inflammatory bowel disease (IBD). One hundred and twenty Crohn's disease (CD) patients, 117 ulcerative colitis (UC) patients and 120 cases of nonspecific colitis provided intestinal biopsy samples for tissue microarray (TMA). Both unsupervised and supervised analyses were used for evaluation of clustering and association with relapse. There was a significant concordance between cluster groups based on immunostaining data of TMA and clinical classification in distinguishing IBD from nonspecific colitis (kappa= 0.498, p<0.001). CD27, CD70, CD40, TRAF3, TRAF4 and TRAF2 presented similar immunostaining features, which were different from clusters of CD154, CD80 and TRAF5. Moreover, higher expression of TRAF2 was a predictor of relapse in patients with UC (p=0.006).Thus, protein expression profiles can distinguish IBD and nonspecific colitis, and combination analysis protein expression profiles show that TRAF2 can predict relapse of UC.
Keywords: Crohn’s disease; classification; relapse; ulcerative colitis.
Figures


Similar articles
-
Up-regulation and pre-activation of TRAF3 and TRAF5 in inflammatory bowel disease.Int J Med Sci. 2013;10(2):156-63. doi: 10.7150/ijms.5457. Epub 2013 Jan 3. Int J Med Sci. 2013. PMID: 23329887 Free PMC article.
-
Fecal calprotectin is useful in predicting disease relapse in pediatric inflammatory bowel disease.Inflamm Bowel Dis. 2008 May;14(5):669-73. doi: 10.1002/ibd.20376. Inflamm Bowel Dis. 2008. PMID: 18240279
-
Immunohistochemical Profile of Tumor Suppressor Proteins RASSF1A and LATS1/2 in Relation to p73 and YAP Expression, of Human Inflammatory Bowel Disease and Normal Intestine.Pathol Oncol Res. 2020 Jan;26(1):567-574. doi: 10.1007/s12253-018-00575-z. Epub 2019 Jan 2. Pathol Oncol Res. 2020. PMID: 30604274
-
Differentiating ulcerative colitis from Crohn disease in children and young adults: report of a working group of the North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition and the Crohn's and Colitis Foundation of America.J Pediatr Gastroenterol Nutr. 2007 May;44(5):653-74. doi: 10.1097/MPG.0b013e31805563f3. J Pediatr Gastroenterol Nutr. 2007. PMID: 17460505
-
Visceral adiposity and inflammatory bowel disease.Int J Colorectal Dis. 2021 Nov;36(11):2305-2319. doi: 10.1007/s00384-021-03968-w. Epub 2021 Jun 9. Int J Colorectal Dis. 2021. PMID: 34104989 Review.
Cited by
-
Tumor Necrosis Factor Receptor-Associated Factor Regulation of Nuclear Factor κB and Mitogen-Activated Protein Kinase Pathways.Front Immunol. 2018 Aug 9;9:1849. doi: 10.3389/fimmu.2018.01849. eCollection 2018. Front Immunol. 2018. PMID: 30140268 Free PMC article. Review.
-
An integrative network-based approach to identify novel disease genes and pathways: a case study in the context of inflammatory bowel disease.BMC Bioinformatics. 2018 Jul 13;19(1):264. doi: 10.1186/s12859-018-2251-x. BMC Bioinformatics. 2018. PMID: 30005591 Free PMC article.
-
Proinflammatory TLR signalling is regulated by a TRAF2-dependent proteolysis mechanism in macrophages.Nat Commun. 2015 Jan 7;6:5930. doi: 10.1038/ncomms6930. Nat Commun. 2015. PMID: 25565375 Free PMC article.
-
Gut-lung crosstalk in pulmonary involvement with inflammatory bowel diseases.World J Gastroenterol. 2013 Oct 28;19(40):6794-804. doi: 10.3748/wjg.v19.i40.6794. World J Gastroenterol. 2013. PMID: 24187454 Free PMC article. Review.
-
CD40 Upregulation in the Retina of Patients With Diabetic Retinopathy: Association With TRAF2/TRAF6 Upregulation and Inflammatory Molecule Expression.Invest Ophthalmol Vis Sci. 2023 Jun 1;64(7):17. doi: 10.1167/iovs.64.7.17. Invest Ophthalmol Vis Sci. 2023. PMID: 37294707 Free PMC article.
References
-
- Carpenter HA, Talley NJ. The importance of clinicopathological correlation in the diagnosis of inflammatory conditions of the colon: histological patterns with clinical implications. Am J Gastroenterol. 2000;95:878–896. - PubMed
-
- Schulze HA, Häsler R, Mah N, Lu T, Nikolaus S, Costello CM, Schreiber S. From model cell line to in vivo gene expression: disease-related intestinal gene expression in IBD. Genes Immun. 2008;9:240–248. - PubMed
-
- Henriksen M, Jahnsen J, Lygren I, Sauar J, Schulz T, Stray N, Vatn MH, Moum B Ibsen Study Group. Change of diagnosis during the first five years after onset of inflammatory bowel disease: results of a prospective follow-up study (the IBSEN Study) Scand J Gastroenterol. 2006;41:1037–1043. - PubMed
-
- Mowat C, Cole A, Windsor A, Ahmad T, Arnott I, Driscoll R, Mitton S, Orchard T, Rutter M, Younge L, Lees C, Ho GT, Satsangi J, Bloom S IBD Section of the British Society of Gastroenterology. Guidelines for the management of inflammatory bowel disease in adults. Gut. 2011;60:571–607. - PubMed
-
- Casellas F, Barreiro de Acosta M, Iglesias M, Robles V, Nos P, Aguas M, Riestra S, de Francisco R, Papo M, Borruel N. Mucosal healing restores normal health and quality of life in patients with inflammatory bowel disease. Eur J Gastroenterol Hepatol. 2012;24:762–769. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials